Mesa Laboratories Company Insiders
MLAB Stock | USD 131.25 4.15 3.06% |
Mesa Laboratories' insiders are aggressively selling. The analysis of insiders' sentiment of trading Mesa Laboratories stock suggests that all insiders are panicking at this time. Mesa Laboratories employs about 736 people. The company is managed by 7 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 105.14 employees per reported executive.
Gary Owens President COO, Vice President |
Mesa Laboratories' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-10-28 | Gary M Owens | Disposed 2518 @ 113.62 | View | ||
2024-09-13 | Brian David Archbold | Disposed 1499 @ 125 | View |
Monitoring Mesa Laboratories' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Mesa |
Mesa Laboratories' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Mesa Laboratories' future performance. Based on our forecasts, it is anticipated that Mesa will maintain a workforce of about 740 employees by January 2025.Mesa Laboratories Management Team Effectiveness
The company has return on total asset (ROA) of 0.0169 % which means that it generated a profit of $0.0169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8946) %, meaning that it created substantial loss on money invested by shareholders. Mesa Laboratories' management efficiency ratios could be used to measure how well Mesa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -1.58. The current year's Return On Capital Employed is expected to grow to -0.64. At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 354.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 823.6 K.As of December 25, 2024, Common Stock Shares Outstanding is expected to decline to about 4.3 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 1 M
Mesa Laboratories Workforce Comparison
Mesa Laboratories is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 9,167. Mesa Laboratories holds roughly 736 in number of employees claiming about 8% of equities under Health Care industry.
Mesa Laboratories Profit Margins
The company has Profit Margin (PM) of (1.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.69 | 0.6164 |
|
|
Mesa Laboratories Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mesa Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mesa Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Mesa Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.5 | 1 | 2 | 11,559 | 5,069 |
2024-09-01 | 1.1538 | 15 | 13 | 20,746 | 15,561 |
2024-06-01 | 0.4286 | 6 | 14 | 48,626 | 17,551 |
2024-03-01 | 0.5 | 1 | 2 | 724.00 | 290.00 |
2023-12-01 | 0.3333 | 1 | 3 | 200.00 | 3,700 |
2023-09-01 | 1.3333 | 16 | 12 | 28,630 | 16,216 |
2023-06-01 | 0.3636 | 12 | 33 | 36,719 | 11,952 |
2023-03-01 | 0.5 | 9 | 18 | 24,279 | 36,549 |
2022-12-01 | 0.3333 | 1 | 3 | 40.00 | 4,155 |
2022-09-01 | 0.963 | 26 | 27 | 26,831 | 30,130 |
2022-06-01 | 0.7931 | 23 | 29 | 63,961 | 24,570 |
2022-03-01 | 0.5 | 5 | 10 | 8,792 | 18,184 |
2021-12-01 | 0.6667 | 16 | 24 | 34,712 | 30,424 |
2021-09-01 | 1.25 | 30 | 24 | 57,923 | 28,544 |
2021-06-01 | 0.6429 | 36 | 56 | 45,892 | 51,269 |
2021-03-01 | 0.3529 | 6 | 17 | 27,225 | 40,541 |
2020-12-01 | 0.7333 | 22 | 30 | 10,233 | 19,630 |
2020-09-01 | 0.5172 | 15 | 29 | 10,448 | 16,979 |
2020-06-01 | 1.9412 | 33 | 17 | 36,089 | 4,787 |
2020-03-01 | 0.6 | 9 | 15 | 12,680 | 32,963 |
2019-12-01 | 1.6 | 16 | 10 | 4,873 | 14,434 |
2019-09-01 | 1.0 | 2 | 2 | 2,720 | 2,720 |
2019-06-01 | 0.8611 | 31 | 36 | 32,561 | 14,431 |
2019-03-01 | 0.3333 | 8 | 24 | 12,084 | 33,332 |
2018-12-01 | 1.3636 | 15 | 11 | 3,770 | 20,650 |
2018-09-01 | 0.4444 | 4 | 9 | 3,920 | 287,462 |
2018-06-01 | 4.5 | 27 | 6 | 35,370 | 30,989 |
2018-03-01 | 0.3077 | 4 | 13 | 5,800 | 50,300 |
2017-09-01 | 0.1 | 1 | 10 | 2,000 | 8,610 |
2017-06-01 | 2.125 | 17 | 8 | 42,980 | 26,700 |
2017-03-01 | 0.3684 | 7 | 19 | 27,914 | 62,062 |
2016-12-01 | 0.3 | 3 | 10 | 4,567 | 15,136 |
2016-06-01 | 1.6667 | 15 | 9 | 35,259 | 10,434 |
2016-03-01 | 0.1667 | 1 | 6 | 1,903 | 7,812 |
2015-12-01 | 0.9167 | 11 | 12 | 16,638 | 19,038 |
2015-09-01 | 0.1 | 1 | 10 | 150.00 | 69,627 |
2015-06-01 | 1.3529 | 23 | 17 | 57,675 | 12,545 |
2015-03-01 | 1.0 | 2 | 2 | 1,950 | 1,950 |
2014-12-01 | 1.3333 | 12 | 9 | 5,370 | 8,650 |
2014-09-01 | 1.0 | 2 | 2 | 14,000 | 14,000 |
2014-06-01 | 4.0 | 16 | 4 | 38,700 | 1,500 |
2014-03-01 | 0.3333 | 2 | 6 | 14,925 | 30,925 |
2013-12-01 | 0.4118 | 7 | 17 | 8,925 | 41,800 |
2013-09-01 | 0.625 | 5 | 8 | 19,000 | 33,000 |
2013-06-01 | 4.0 | 12 | 3 | 22,550 | 1,350 |
2013-03-01 | 0.5556 | 5 | 9 | 10,275 | 43,001 |
2012-12-01 | 0.2727 | 3 | 11 | 11,240 | 48,271 |
2012-06-01 | 1.9 | 19 | 10 | 34,875 | 13,075 |
2012-03-01 | 1.4 | 14 | 10 | 27,180 | 38,264 |
2011-06-01 | 1.7692 | 23 | 13 | 45,875 | 22,225 |
2011-03-01 | 2.0 | 2 | 1 | 20,000 | 10,000 |
2010-12-01 | 2.0 | 10 | 5 | 152,775 | 70,985 |
2010-06-01 | 2.0 | 20 | 10 | 42,600 | 15,522 |
2010-03-01 | 0.4 | 2 | 5 | 5,025 | 10,369 |
2009-12-01 | 0.6667 | 10 | 15 | 55,475 | 48,864 |
2009-06-01 | 2.5 | 10 | 4 | 29,000 | 6,175 |
2008-12-01 | 0.4 | 2 | 5 | 11,940 | 18,000 |
2008-09-01 | 1.0 | 2 | 2 | 1,750 | 1,750 |
2008-06-01 | 2.5 | 10 | 4 | 20,475 | 105,500 |
2007-12-01 | 0.2222 | 2 | 9 | 4,000 | 32,630 |
2007-09-01 | 1.0 | 6 | 6 | 5,500 | 11,750 |
2007-06-01 | 1.75 | 7 | 4 | 53,000 | 14,000 |
2007-03-01 | 0.8333 | 5 | 6 | 4,400 | 7,425 |
2006-12-01 | 0.6667 | 4 | 6 | 10,500 | 15,700 |
2006-06-01 | 1.3333 | 8 | 6 | 16,100 | 8,000 |
2006-03-01 | 1.0667 | 16 | 15 | 77,100 | 75,846 |
2005-12-01 | 1.1111 | 10 | 9 | 21,832 | 21,000 |
2005-09-01 | 0.5 | 1 | 2 | 1,500 | 1,974 |
2005-06-01 | 7.0 | 7 | 1 | 20,000 | 675.00 |
2004-12-01 | 0.4286 | 3 | 7 | 7,500 | 32,840 |
2004-09-01 | 1.0 | 5 | 5 | 17,500 | 10,350 |
2004-03-01 | 1.0 | 1 | 1 | 4,000 | 4,000 |
2003-12-01 | 0.8571 | 12 | 14 | 36,000 | 43,200 |
Mesa Laboratories Notable Stakeholders
A Mesa Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mesa Laboratories often face trade-offs trying to please all of them. Mesa Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mesa Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gary Owens | COO, Vice President | Profile | |
John Sakys | CFO, Chief Accounting Officer and Secretary | Profile | |
John CPA | CFO VP | Profile | |
Peter Dansky | Pres Genomics | Profile | |
Brian Archbold | Senior Improvement | Profile | |
Bryan Leo | VP Operations | Profile | |
Garrett Krushefski | VP Operations | Profile |
About Mesa Laboratories Management Performance
The success or failure of an entity such as Mesa Laboratories often depends on how effective the management is. Mesa Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mesa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mesa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.66) | (1.58) | |
Return On Capital Employed | (0.68) | (0.64) | |
Return On Assets | (0.57) | (0.54) | |
Return On Equity | (1.75) | (1.66) |
Please note, the presentation of Mesa Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mesa Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mesa Laboratories' management manipulating its earnings.
Mesa Laboratories Workforce Analysis
Traditionally, organizations such as Mesa Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mesa Laboratories within its industry.Mesa Laboratories Manpower Efficiency
Return on Mesa Laboratories Manpower
Revenue Per Employee | 293.7K | |
Revenue Per Executive | 30.9M | |
Net Loss Per Employee | 345.4K | |
Net Loss Per Executive | 36.3M | |
Working Capital Per Employee | 88.4K | |
Working Capital Per Executive | 9.3M |
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |